Virtual visit appointments available 7 days a week from 9:00am to 11:00pm. Learn More
Texas Medical Center
Specialty
Cancer and Hematology
Phone: 832-824-3983
Fax: 832-825-1453
Email
seconnee@texaschildrens.org
Address
6701 Fannin, Ste. 1510
Houston, TX 77030
Research Area
Shannon E. Conneely, MD
Assistant Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor College of Medicine | Fellowship | Pediatric Hematology-Oncology | 2020 |
| Cincinnati Children's Hospital Medical Center | Residency | Pediatrics | 2016 |
| University of Cincinnati College of Medicine | Medical School | Doctor of Medicine | 2013 |
| Ohio State University | Bachelors | Bachelor of Science, Biomedical Science | 2009 |
About
Dr. Shannon Conneely completed her pediatric hematology/oncology fellowship training in 2020. Prior to her fellowship training, she worked at Texas Children's Hospital on the inpatient oncology unit as a hospitalist assisting in the medical care of a variety of pediatric oncology patients.
She developed an interest in pediatric cancer care as a high school student volunteering at her local children's hospital in Ohio. She hopes to help many children to live full and happy lives after a cancer diagnosis while minimizing the side effects of cancer therapy.
She is board certified by the American Board of Pediatrics.
Organizations
| Organization Name | Role |
|---|---|
| American Academy of Pediatrics (AAP) | Member |
| American Society of Clinical Oncology (ASCO) | Member |
| American Society of Hematology (ASH) | Member |
| American Society of Pediatric Hematology/Oncology (ASPHO) | Member |
| Children's Oncology Group (COG) | Member |
Research Statement
Dr. Conneely's research focuses on better understanding the mechanism behind certain types of leukemia, specifically acute myeloid leukemia (AML). She is trying to identify protein interactions that either help or prevent AML cells from dividing and driving disease. The overall goal is to identify potential new pathways that can be targeted for therapies in the future to improve outcomes for patients with AML.
Selected Publications
Board Certification
American Board of Pediatrics
Language
English
* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.